Missing or inadequate procedures for out-of-specification (OOS) results and failure investigations are among the most common deviations cited in FDA warning letters. This OOS and OOT investigations webinar reviews the regulatory requirements and how to meet them.
You'll follow the process from detecting an OOS result through the Phase I laboratory investigation and a Phase II full-scale investigation to concluding it, using a detailed flow chart that shows each step and its order.
The session explains the responsibilities of the analyst, supervisor and QA, how to structure an investigation report, how to handle out-of-trend (OOT) results and common pitfalls, with a review of OOS-related warning letter citations.
WHY SHOULD YOU ATTEND?
Most companies have OOS procedures, but they are often inadequate or not followed. This session guides you through the full process, from detecting an OOS result to informal and formal laboratory and batch investigations, so your procedures hold up.
It suits QA/QC and regulatory affairs directors, managers and specialists, and quality control laboratory staff.
AREA COVERED
- Regulatory requirements for OOS investigations
- Responsibilities of the analyst, supervisor and QA
- Phase I: the laboratory investigation
- Phase II: the full-scale investigation
- Concluding an investigation and structuring the report
- Out-of-trend investigations
- Common pitfalls during OOS investigations
- OOS-related citations in FDA warning letters
LEARNING OBJECTIVES
- Explain the regulatory requirements for investigating OOS results
- Define the roles of the analyst, supervisor and QA
- Conduct a Phase I laboratory investigation and a Phase II full-scale investigation
- Write an investigation report that documents the work properly
- Investigate out-of-trend results
- Avoid common pitfalls seen in warning letters
WHO WILL BENEFIT?
- Quality Assurance/Quality Control Directors, Managers, and Specialists
- Regulatory Affairs/Regulatory Compliance Directors, Managers, and Specialists
- Quality Control Laboratory Staff
Most companies have OOS procedures, but they are often inadequate or not followed. This session guides you through the full process, from detecting an OOS result to informal and formal laboratory and batch investigations, so your procedures hold up.
It suits QA/QC and regulatory affairs directors, managers and specialists, and quality control laboratory staff.
- Regulatory requirements for OOS investigations
- Responsibilities of the analyst, supervisor and QA
- Phase I: the laboratory investigation
- Phase II: the full-scale investigation
- Concluding an investigation and structuring the report
- Out-of-trend investigations
- Common pitfalls during OOS investigations
- OOS-related citations in FDA warning letters
- Explain the regulatory requirements for investigating OOS results
- Define the roles of the analyst, supervisor and QA
- Conduct a Phase I laboratory investigation and a Phase II full-scale investigation
- Write an investigation report that documents the work properly
- Investigate out-of-trend results
- Avoid common pitfalls seen in warning letters
- Quality Assurance/Quality Control Directors, Managers, and Specialists
- Regulatory Affairs/Regulatory Compliance Directors, Managers, and Specialists
- Quality Control Laboratory Staff
Speaker Profile
Danielle DeLucy
Danielle DeLucy, MS, is owner of ASA Training and Consulting, LLC which provides Pharmaceutical and Biologics based companies with training and quality systems assistance in order to meet Regulatory compliance. Prior to this role, Danielle has been in the industry for 15 years serving in numerous Quality Management Roles, such as the Director of Product Quality, the oversight of Sterility Assurance practices and provided QA oversight of numerous filling and packaging operations. Danielle began her QA career as a Quality Control Pharmaceutical Microbiologist at a contract laboratory where she performed various tests for their clients. In the years after, she …
Upcoming Webinars
New Form I-9: Documents and Policies that Ensure ICE I-9 Co…
Claude AI For CPAs & Finance Professionals: Best Practices …
Secrets Of Psychology - Why People Do The Things They Do
2-Hour Virtual Seminar on How to Conduct an Internal Harass…
Project Management For Administrative Professionals
Onboarding is NOT Orientation - How to Improve the New Empl…
Elevate Your Workplace Wellness: 10 Critical Wellness Facto…
Managing Complex Projects - Project Management
Utilizing HR Metrics to Illustrate & Improve Human Resource…
Negotiating Skills For Professional Results - Winning Strat…
NEW Nacha Rule - Third-Party Sender (TPS) Roles and Respons…
Paying and Receiving Payments for Referrals: You Can Go to …
FDA Technology Modernization Action Plan (TMAP) and Impact …
Human Factors Usability Studies Following ISO 62366 and FDA…
Construction Lending And Real Credit Administration: Evalua…
Validation Statistics for Non-Statisticians
Thriving in a Hybrid Workplace: Keys to Leadership and Team…
Excel Power Skills: Master Functions, Formulas, and Macros …
Batch Record Review and Product Release
Discover how Emotional Intelligence turns AI from a technic…
Copilot and HR: An Introduction for HR Professionals
ChatGPT for HR - Build HR Policy Framework and Strategy
Female to Female Hostility @Workplace: All you Need to Know